0.8899
price down icon0.45%   -0.004
 
loading

Oncology Institute Inc (TOI) 最新ニュース

pulisher
Feb 21, 2025

Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9%Time to Sell? - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

A groundbreaking project at the Oncology Institute in Shaare Zedek Medical Center - The Jerusalem Post

Feb 20, 2025
pulisher
Feb 10, 2025

In the Green: Oncology Institute Inc (TOI) Closes at 0.82, Up/Down -7.68 from Previous Day - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Oncology Institute Inc [TOI] Investment Appeal on the Rise - Knox Daily

Feb 10, 2025
pulisher
Feb 06, 2025

Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex

Feb 06, 2025
pulisher
Feb 05, 2025

Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying - Yahoo Finance

Feb 05, 2025
pulisher
Feb 04, 2025

Oncology Institute Inc (TOI) Stock: A Year of Market Fluctuations - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Oncology Institute Inc [TOI] Stock bought by Insider Hively Brad for $42500.0 - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

The Oncology Institute Inc (TOI) had a good session last reading, didn’t it? - US Post News

Feb 04, 2025
pulisher
Feb 03, 2025

Why The Oncology Institute (TOI) Is Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025
pulisher
Feb 03, 2025

The Oncology Institute, Inc. (NASDAQ:TOI) Sees Large Growth in Short Interest - MarketBeat

Feb 03, 2025
pulisher
Jan 18, 2025

The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 195% But Many Are Still Ignoring The Company - Simply Wall St

Jan 18, 2025
pulisher
Jan 07, 2025

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection - Business Wire

Jan 07, 2025
pulisher
Jan 07, 2025

Guardant Health's Shield Cancer Test Selected for Major NCI Study Covering 10 Cancer Types - StockTitan

Jan 07, 2025
pulisher
Dec 31, 2024

The Oncology Institute Inc WT (TOIIW-Q) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 27, 2024

HighTower Advisors LLC Has $27,000 Stock Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World

Dec 27, 2024
pulisher
Dec 20, 2024

Oncology Institute faces potential Nasdaq delisting - Investing.com

Dec 20, 2024
pulisher
Dec 18, 2024

Florida Blue enhances cancer care for thousands of members - The Manila Times

Dec 18, 2024
pulisher
Dec 18, 2024

Florida Blue Launches Breakthrough Cancer Care Program with The Oncology Institute Partnership - StockTitan

Dec 18, 2024
pulisher
Dec 03, 2024

Brian Druker resigns as OHSU Knight Cancer Institute CEO - Portland Business Journal

Dec 03, 2024
pulisher
Dec 02, 2024

Oncology institute director Brad Hively acquires $50,000 in stock - Investing.com

Dec 02, 2024
pulisher
Dec 02, 2024

Oncology institute director Brad Hively acquires $50,000 in stock By Investing.com - Investing.com UK

Dec 02, 2024
pulisher
Dec 02, 2024

Tomorrow’s Promise, Today’s Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment - Roswell Park Comprehensive Cancer Center

Dec 02, 2024
pulisher
Dec 01, 2024

2024 Face of Hope: Carolina BioOncology Institute - Charlotte magazine

Dec 01, 2024
pulisher
Nov 29, 2024

Despite Recent Gains, Oncology Institute Insiders Are Still Down US$110k - Simply Wall St

Nov 29, 2024
pulisher
Nov 26, 2024

Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire

Nov 26, 2024
pulisher
Nov 21, 2024

Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Markets Insider

Nov 21, 2024
pulisher
Nov 21, 2024

Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register

Nov 21, 2024
pulisher
Nov 20, 2024

Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

RenovoRx Expands Phase III Pancreatic Cancer Trial with Major Cancer Institute Partnership - StockTitan

Nov 20, 2024
pulisher
Nov 16, 2024

Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

USF and TGH partner with robotics company to become the first to bring life-saving surgical technology to Tampa Bay - University of South Florida

Nov 15, 2024
pulisher
Nov 14, 2024

Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com

Nov 14, 2024
pulisher
Nov 13, 2024

Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

The Oncology Institute Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Oncology Institute Q3 Revenue Jumps 22% to $99.9M Despite Margin Pressure | TOI Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Oncology Institute Announces Board Changes for 2025 - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib - BioSpace

Nov 12, 2024
pulisher
Nov 11, 2024

The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Oncology Institute (TOI) Launches Groundbreaking Outpatient Cancer Treatment Service | TOI Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 04, 2024

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com

Nov 04, 2024
pulisher
Nov 03, 2024

Cancer Care - WellSpan Health

Nov 03, 2024
pulisher
Nov 03, 2024

Bayhealth welcomes new hematologist oncologist to cancer institute - CapeGazette.com

Nov 03, 2024
pulisher
Oct 29, 2024

GlycoMimetics, Inc. Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire

Oct 29, 2024
$39.65
price down icon 2.51%
$32.00
price down icon 1.20%
$126.34
price down icon 0.89%
medical_care_facilities CHE
$546.24
price down icon 0.70%
medical_care_facilities EHC
$97.53
price down icon 2.36%
medical_care_facilities UHS
$180.03
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):